Table of Content

1. Table of Contents
1.1 List of Tables
1.2 List of Figures


2. Executive Summary
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 Lung Cancer Diagnostics Market- Key Findings, 2020


3. Strategic Imperatives on Global Lung Cancer Diagnostics Market
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key Lung Cancer Diagnostics Companies


4. Lung Cancer Diagnostics Market Value Outlook to 2026 Outlook By Type
4.1 Small Cell Lung Cancer
4.2 Non-small Cell Lung Cancer


5. Lung Cancer Diagnostics Market Value Outlook to 2026 Outlook By Test
5.1 Biopsy
5.2 Sputum Cytology
5.3 Molecular Test
5.4 Imaging Test
5.5 Others


6 Asia Pacific Lung Cancer Diagnostics Market Value Outlook to 2026
6.1 Leading Lung Cancer Diagnostics Types contributing to Asia Pacific market
6.2 Top Applications contributing to Asia Pacific Lung Cancer Diagnostics
6.3 Top countries contributing to Asia Pacific Lung Cancer Diagnostics


7 Europe Lung Cancer Diagnostics Market Value Outlook to 2026
7.1 Leading Lung Cancer Diagnostics Types contributing to Europe market
7.2 Top Applications contributing to Europe Lung Cancer Diagnostics
7.3 Top countries contributing to Europe Lung Cancer Diagnostics


8 North America Lung Cancer Diagnostics Market Value Outlook to 2026
8.1 Leading Lung Cancer Diagnostics Types contributing to North America market
8.2 Top Applications contributing to North America Lung Cancer Diagnostics
8.3 Top countries contributing to North America Lung Cancer Diagnostics


9 South and Central America Lung Cancer Diagnostics Market Value Outlook to 2026
9.1 Leading Lung Cancer Diagnostics Types contributing to South and Central America market
9.2 Top Applications contributing to South and Central America Lung Cancer Diagnostics
9.3 Top countries contributing to South and Central America Lung Cancer Diagnostics


10 Middle East Africa Lung Cancer Diagnostics Market Value Outlook to 2026
10.1 Leading Lung Cancer Diagnostics Types contributing to Middle East Africa market
10.2 Top Applications contributing to Middle East Africa Lung Cancer Diagnostics
10.3 Top countries contributing to Middle East Africa Lung Cancer Diagnostics


11 Business Profiles of Leading Companies
11.1 Business Description, SWOT and Financial Analysis of Companies in Lung Cancer Diagnostics market
11.2 Agilent Technologies
11.3 AstraZeneca plc
11.4 BioMerieux
11.5 Illumina Inc.
11.6 Janssen Pharmaceuticals, Inc.
11.7 Qiagen N.V.
11.8 Roche Diagnostics
11.9 SanofiS.A.
11.10 Thermo Fisher Scientific


12 Recent Industry Developments


13 Appendix
13.1 OGAnalysis Expertise
13.2 Sources and Methodology
13.3 Contacts